AWARE-HF: Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management

Sponsor
Seoul National University Bundang Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02673073
Collaborator
(none)
1,220
1
2
47
26

Study Details

Study Description

Brief Summary

Before a HF patient gets maximally decompensated and visit emergency department, most patients experience symptoms and signs of "on-going decompensation (or pre-decompensation)", which may not be noticed by the patients. If HF patients were aware of symptoms and signs of ADHF and received early intervention to stop the process of "on-going decompensation (or pre-decompensation)", it would be possible to reduce the rate of hospitalization for ADHF or death. Thus, self-awareness and self-examination of heart failure symptoms, signs and medical compliance using a patient diary in HF management may improve the outcomes in chronic stable HF patients. A patient diary with 6 parameters can serve this purpose: body weight, blood pressure, heart rate, drug compliance expressed as number of remaining pills of previous day, edema grade, and dyspnea grade.

Condition or Disease Intervention/Treatment Phase
  • Other: Patient's diary
  • Other: Patient's education
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1220 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management (AWARE-HF)
Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2018
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control_Education

All patients will receive patient's information/education booklet on the heart failure including life style modification.

Other: Patient's education
All patients will receive patient's information/education booklet on the heart failure including life style modification.

Experimental: Intervention_Diary

All patients will receive patient's information/education booklet on the heart failure including life style modification. In addition, patients also receive a patient's diary for self-recording of 6 parameters: body weight, blood pressure, heart rate, number of remaining pills, degree of pitting edema, and degree of dyspnea.

Other: Patient's diary
Patients in the intervention arm will be educated to measure body weight, blood pressure, and heart rate every morning after using toilet. Number of remaining pills of the previous day is for the assessment of drug compliance. Degree of pitting edema is graded from 0 (no edema), 1 (mild), 2 (moderate), 3 (severe) and, degree of dyspnea is graded from 0, 1, 2, 3, corresponding to NYHA class I, II, III, and IV, respectively. Patients are instructed to visit or call the HF-outpatient clinic, when they have (i) body weight gain more than 1 kg/day or 2kg in 7 days;(ii) aggravation of pitting edema by one degree; (iii) aggravation of dyspnea by one grade.

Outcome Measures

Primary Outcome Measures

  1. Composite of all-cause death or rehospitalization [1 year]

    Data on primary and secondary measures will be collected a trained study coordinator, using a standardized case report form.

Secondary Outcome Measures

  1. all-cause death [1 year]

  2. cardiovascular death [1 year]

  3. admission for acute heart failure [1 year]

  4. drug compliance [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who are 18 years or older

  • Patients admitted for acute heart failure and scheduled for discharge after medical stabilization

  • Chronic stable heart failure patients with a history of hospitalization for AHF

Exclusion Criteria:
  • Patients with limited cognitive function who cannot not perform self-recording (in case that the patient has a family member who can perform the recording, the patient can be rerolled)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Bundang Hospital Seongnam Korea, Republic of 463707

Sponsors and Collaborators

  • Seoul National University Bundang Hospital

Investigators

  • Principal Investigator: Jin Joo Park, MD, Seoul National University Bundang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dong-Ju Choi, MD, PhD, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT02673073
Other Study ID Numbers:
  • AWARE-HF
First Posted:
Feb 3, 2016
Last Update Posted:
Oct 13, 2016
Last Verified:
Oct 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Dong-Ju Choi, MD, PhD, Seoul National University Bundang Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2016